Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Squamous Cell Carcinoma of Head and Neck 14Oropharyngeal Neoplasms 12Lung Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Mouth Neoplasms 8Laryngeal Neoplasms 8Carcinoma 8Small Cell Lung Carcinoma 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Nasopharyngeal Carcinoma 6Hypopharyngeal Neoplasms 6Pancreatic Neoplasms 5Mesothelioma, Malignant 5Triple Negative Breast Neoplasms 4Medulloblastoma 4Ganglioneuroblastoma 4Gallbladder Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Neuroblastoma 3Lymphoid Interstitial Pneumonia 3Fallopian Tube Neoplasms 3Cholangiocarcinoma 3Carcinoma, Transitional Cell 3Adenocarcinoma of Lung 3Testicular Neoplasms 2

Interventions

Carboplatin 9pembrolizumab 7Pemetrexed 7Radiotherapy 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Radiation 4Nivolumab 4Bevacizumab 4Platinum 3Paclitaxel 3Mastectomy, Segmental 3Cisplatin 3Biopsy 3fludarabine phosphate 2durvalumab 2capmatinib 2aldesleukin 2Taxes 2Radiotherapy, Conformal 2Radiosurgery 2Ipilimumab 2Interleukin-2 2Immunoglobulin G 2Disulfides 2Cyclophosphamide 2CTLA-4 Antigen 2Anterior Temporal Lobectomy 21,2-diaminocyclohexaneplatinum II citrate 2veliparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Platinum × 1 year × Clear all
NCT05198830 2026-05-27

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Recruiting
42 enrolled
Thoracic

Adenocarcinoma of Lung, Lung Neoplasms

NCT00334815 2026-05-26

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
29 enrolled 10 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

NCT07416058 2026-02-17

PHOENIX

Guangdong Association of Clinical Trials

Phase 2 Not yet recruiting
61 enrolled
Thoracic

Diabetes Mellitus, Insulin-Dependent, 12, Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡